Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-06-01 16:22:20
Reporting Period:
Accepted Time:
2018-06-01 16:22:20
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476151 A Enrique Conterno Lilly Corporate Center
Indianapolis IN 46285
Svp&pres, Lillydiab & Lillyusa No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-05-31 25,000 $85.00 124,534 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,084 Indirect 401(k)
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2018.
  2. This transaction was executed in multiple trades at prices ranging from $85.00 to $85.03. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.